These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3856652)

  • 1. On the comparative ethnopharmacology of malpighiaceous and myristicaceous hallucinogens.
    McKenna DJ; Towers GH
    J Psychoactive Drugs; 1985; 17(1):35-9. PubMed ID: 3856652
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoamine oxidase inhibitors in South American hallucinogenic plants Part 2: Constituents of orally-active Myristicaceous hallucinogens.
    McKenna DJ; Towers GH; Abbott FS
    J Ethnopharmacol; 1984 Nov; 12(2):179-211. PubMed ID: 6521493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.
    McKenna DJ; Towers GH; Abbott F
    J Ethnopharmacol; 1984 Apr; 10(2):195-223. PubMed ID: 6587171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions.
    Liester MB; Prickett JI
    J Psychoactive Drugs; 2012; 44(3):200-8. PubMed ID: 23061319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered consciousness states and endogenous psychoses: a common molecular pathway?
    Ciprian-Ollivier J; Cetkovich-Bakmas MG
    Schizophr Res; 1997 Dec; 28(2-3):257-65. PubMed ID: 9468359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemistry and pharmacology of tryptamines and beta-carbolines. A minireview.
    McKenna DJ; Towers GH
    J Psychoactive Drugs; 1984; 16(4):347-58. PubMed ID: 6394730
    [No Abstract]   [Full Text] [Related]  

  • 7. Participation of retinal mechanisms in DMT hallucinations.
    Heiss WD; Hoyer J; Poustka F
    Experientia; 1973 Apr; 29(4):455-7. PubMed ID: 4513543
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans.
    Strassman RJ; Qualls CR; Berg LM
    Biol Psychiatry; 1996 May; 39(9):784-95. PubMed ID: 8731519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reassessing the cultural and psychopharmacological significance of Banisteriopsis caapi: preparation, classification and use among the Piaroa of Southern Venezuela.
    Rodd R
    J Psychoactive Drugs; 2008 Sep; 40(3):301-7. PubMed ID: 19004422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative behavioral effects of N,N-dimethyltryptamine and N,N-diethyltryptamine in primate dyads.
    Heinze WJ; Schlemmer RF; Tyler CB; Davis JM
    Biol Psychiatry; 1983 Jul; 18(7):829-36. PubMed ID: 6577915
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8. Miscellaneous notes on Myristicaceous plants of South America.
    Schultes RE; Holmstedt B
    Lloydia; 1971 Mar; 34(1):61-78. PubMed ID: 5140266
    [No Abstract]   [Full Text] [Related]  

  • 13. Ayahoasca: an experimental psychosis that mirrors the transmethylation hypothesis of schizophrenia.
    Pomilio AB; Vitale AA; Ciprian-Ollivier J; Cetkovich-Bakmas M; Gómez R; Vázquez G
    J Ethnopharmacol; 1999 Apr; 65(1):29-51. PubMed ID: 10350367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional ethnopharmacology: Turbina corymbosa (L.) Raf.
    Huxtable RJ
    Proc West Pharmacol Soc; 1994; 37():1-2. PubMed ID: 7984631
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmepéna-Psychonautics: Human intranasal, sublingual and oral pharmacology of 5-methoxy-N,N-dimethyl-tryptamine.
    Ott J
    J Psychoactive Drugs; 2001; 33(4):403-7. PubMed ID: 11824699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a hallucinogen, 5-methoxy N,N-dimethyltryptamine, on primate social behavior.
    Schlemmer RF; Narasimhachari N; Thompson VD; Davis JM
    Commun Psychopharmacol; 1977; 1(2):105-18. PubMed ID: 414877
    [No Abstract]   [Full Text] [Related]  

  • 17. Basics of the medical use of ayahuasca: physiology of dimethyltryptamine.
    Ede F; Attila K; Attila S; Csaba F; Csaba M
    Lege Artis Med; 2016; 26(9-10):413. PubMed ID: 29537778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toxic ecstasy].
    Leuner H
    Bibl Psychiatr Neurol; 1968; 134():73-114. PubMed ID: 5753775
    [No Abstract]   [Full Text] [Related]  

  • 19. The beta-carboline hallucinogens of South America.
    Schultes RE
    J Psychoactive Drugs; 1982; 14(3):205-20. PubMed ID: 6754896
    [No Abstract]   [Full Text] [Related]  

  • 20. The prevention by inhibitors of brain proptein synthesis of the hyperactivity and hyperpyrexia produced in rats by monoamine oxidase inhibition and the administration of L-tryptophan or 5-methoxy-N,N-dimethyltryptamine.
    Grahame-Smith DG
    J Neurochem; 1972 Oct; 19(10):2409-22. PubMed ID: 4512286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.